| 000 | 01622 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514002024.0 | ||
| 264 | 0 | _c20010726 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/1097-0215(20010720)95:4<205::aid-ijc1035>3.0.co;2-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrouillet, J P | |
| 245 | 0 | 0 |
_aAnalysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cJul 2001 |
||
| 300 |
_a205-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoassay _xmethods |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xisolation & purification |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aTamoxifen _xpharmacology |
| 700 | 1 | _aDujardin, M A | |
| 700 | 1 | _aChalbos, D | |
| 700 | 1 | _aRey, J M | |
| 700 | 1 | _aGrenier, J | |
| 700 | 1 | _aLamy, P J | |
| 700 | 1 | _aMaudelonde, T | |
| 700 | 1 | _aPujol, P | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 95 _gno. 4 _gp. 205-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0215(20010720)95:4<205::aid-ijc1035>3.0.co;2-y _zAvailable from publisher's website |
| 999 |
_c11330603 _d11330603 |
||